跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack
Approved
STANDARD
MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ae9f0db8690c4b98
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
ae9f0db8690c4b98
Product Name
MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack
Artg Id
310164
Artg Name
MEVADOL FORTE paracetamol 450 mg/codeine phosphate hemihydrate 30 mg/doxylamine succinate 5 mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2019-12-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9c2bfce664dd33f755c8539cc57332fe.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/175586739159e4cd74e3689c6a1a485b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ae9f0db8690c4b98
Type
Standard
Back to TGA Approvals